294 related articles for article (PubMed ID: 15175264)
1. Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase.
Stojic L; Mojas N; Cejka P; Di Pietro M; Ferrari S; Marra G; Jiricny J
Genes Dev; 2004 Jun; 18(11):1331-44. PubMed ID: 15175264
[TBL] [Abstract][Full Text] [Related]
2. Methylator-induced, mismatch repair-dependent G2 arrest is activated through Chk1 and Chk2.
Adamson AW; Beardsley DI; Kim WJ; Gao Y; Baskaran R; Brown KD
Mol Biol Cell; 2005 Mar; 16(3):1513-26. PubMed ID: 15647386
[TBL] [Abstract][Full Text] [Related]
3. CHK1 and CHK2 are differentially involved in mismatch repair-mediated 6-thioguanine-induced cell cycle checkpoint responses.
Yan T; Desai AB; Jacobberger JW; Sramkoski RM; Loh T; Kinsella TJ
Mol Cancer Ther; 2004 Sep; 3(9):1147-57. PubMed ID: 15367709
[TBL] [Abstract][Full Text] [Related]
4. DNA damage induced by temozolomide signals to both ATM and ATR: role of the mismatch repair system.
Caporali S; Falcinelli S; Starace G; Russo MT; Bonmassar E; Jiricny J; D'Atri S
Mol Pharmacol; 2004 Sep; 66(3):478-91. PubMed ID: 15322239
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage.
Syljuåsen RG; Sørensen CS; Hansen LT; Fugger K; Lundin C; Johansson F; Helleday T; Sehested M; Lukas J; Bartek J
Mol Cell Biol; 2005 May; 25(9):3553-62. PubMed ID: 15831461
[TBL] [Abstract][Full Text] [Related]
6. N-methyl-N'-nitro-N-nitrosoguanidine activates cell-cycle arrest through distinct mechanisms activated in a dose-dependent manner.
Beardsley DI; Kim WJ; Brown KD
Mol Pharmacol; 2005 Oct; 68(4):1049-60. PubMed ID: 15994368
[TBL] [Abstract][Full Text] [Related]
7. Cadmium-induced DNA damage triggers G(2)/M arrest via chk1/2 and cdc2 in p53-deficient kidney proximal tubule cells.
Bork U; Lee WK; Kuchler A; Dittmar T; Thévenod F
Am J Physiol Renal Physiol; 2010 Feb; 298(2):F255-65. PubMed ID: 19923412
[TBL] [Abstract][Full Text] [Related]
8. MSH2 and ATR form a signaling module and regulate two branches of the damage response to DNA methylation.
Wang Y; Qin J
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15387-92. PubMed ID: 14657349
[TBL] [Abstract][Full Text] [Related]
9. ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts.
Yoshioka K; Yoshioka Y; Hsieh P
Mol Cell; 2006 May; 22(4):501-10. PubMed ID: 16713580
[TBL] [Abstract][Full Text] [Related]
10. Bifunctional DNA alkylator 1,3-bis(2-chloroethyl)-1-nitrosourea activates the ATR-Chk1 pathway independently of the mismatch repair pathway.
Cui B; Johnson SP; Bullock N; Ali-Osman F; Bigner DD; Friedman HS
Mol Pharmacol; 2009 Jun; 75(6):1356-63. PubMed ID: 19261750
[TBL] [Abstract][Full Text] [Related]
11. Role of c-Abl kinase in DNA mismatch repair-dependent G2 cell cycle checkpoint arrest responses.
Wagner MW; Li LS; Morales JC; Galindo CL; Garner HR; Bornmann WG; Boothman DA
J Biol Chem; 2008 Aug; 283(31):21382-93. PubMed ID: 18480061
[TBL] [Abstract][Full Text] [Related]
12. Interactions of human mismatch repair proteins MutSalpha and MutLalpha with proteins of the ATR-Chk1 pathway.
Liu Y; Fang Y; Shao H; Lindsey-Boltz L; Sancar A; Modrich P
J Biol Chem; 2010 Feb; 285(8):5974-82. PubMed ID: 20029092
[TBL] [Abstract][Full Text] [Related]
13. Distinct roles for DNA-PK, ATM and ATR in RPA phosphorylation and checkpoint activation in response to replication stress.
Liu S; Opiyo SO; Manthey K; Glanzer JG; Ashley AK; Amerin C; Troksa K; Shrivastav M; Nickoloff JA; Oakley GG
Nucleic Acids Res; 2012 Nov; 40(21):10780-94. PubMed ID: 22977173
[TBL] [Abstract][Full Text] [Related]
14. Mismatch repair-mediated G2/M arrest by 6-thioguanine involves the ATR-Chk1 pathway.
Yamane K; Taylor K; Kinsella TJ
Biochem Biophys Res Commun; 2004 May; 318(1):297-302. PubMed ID: 15110787
[TBL] [Abstract][Full Text] [Related]
15. The alkylating carcinogen N-methyl-N'-nitro-N-nitrosoguanidine activates the plasminogen activator inhibitor-1 gene through sequential phosphorylation of p53 by ATM and ATR kinases.
Vidal B; Parra M; Jardí M; Saito S; Appella E; Muñoz-Cánoves P
Thromb Haemost; 2005 Mar; 93(3):584-91. PubMed ID: 15735814
[TBL] [Abstract][Full Text] [Related]
16. Dissecting cellular responses to irradiation via targeted disruptions of the ATM-CHK1-PP2A circuit.
Palii SS; Cui Y; Innes CL; Paules RS
Cell Cycle; 2013 Apr; 12(7):1105-18. PubMed ID: 23462183
[TBL] [Abstract][Full Text] [Related]
17. Exonuclease 1 (Exo1) is required for activating response to S(N)1 DNA methylating agents.
Izumchenko E; Saydi J; Brown KD
DNA Repair (Amst); 2012 Dec; 11(12):951-64. PubMed ID: 23062884
[TBL] [Abstract][Full Text] [Related]
18. Carcinogen-induced S-phase arrest is Chk1 mediated and caffeine sensitive.
Guo N; Faller DV; Vaziri C
Cell Growth Differ; 2002 Feb; 13(2):77-86. PubMed ID: 11864911
[TBL] [Abstract][Full Text] [Related]
19. High doses of SN1 type methylating agents activate DNA damage signaling cascades that are largely independent of mismatch repair.
Stojic L; Cejka P; Jiricny J
Cell Cycle; 2005 Mar; 4(3):473-7. PubMed ID: 15684614
[TBL] [Abstract][Full Text] [Related]
20. p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage.
Reinhardt HC; Aslanian AS; Lees JA; Yaffe MB
Cancer Cell; 2007 Feb; 11(2):175-89. PubMed ID: 17292828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
